HBV detection based on CRISPR/Cas system

The invention provides brand-new HBV recognition targets (region 1 and region 2), and further provides brand-new crRNA. The sequence of the crRNA disclosed by the invention can be as shown in SEQ ID NO. 3 or SEQ ID NO. 4. The invention also provides a kit based on CRISPR, and the kit comprises any o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YUAN MINGZHU, DUAN GUANGCAI, YANG HAIYAN, XI YUANLIN, DING RONGHUA, JIN LEFEI, CHEN SHUAIYIN
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YUAN MINGZHU
DUAN GUANGCAI
YANG HAIYAN
XI YUANLIN
DING RONGHUA
JIN LEFEI
CHEN SHUAIYIN
description The invention provides brand-new HBV recognition targets (region 1 and region 2), and further provides brand-new crRNA. The sequence of the crRNA disclosed by the invention can be as shown in SEQ ID NO. 3 or SEQ ID NO. 4. The invention also provides a kit based on CRISPR, and the kit comprises any one of the crRNA. On the premise of ensuring the detection sensitivity, the detection technology can improve the HBV detection efficiency and reduce the detection cost, does not depend on professional equipment and technicians, and has the advantages of being easy to popularize and the like. 本发明提供了全新的HBV识别靶点region1、region2,还提供了全新的crRNA。本发明的crRNA,其序列可如SEQ ID NO.3或SEQ ID NO.4所示。本发明还提供了基于CRISPR的试剂盒,其包含任一所述crRNA。本专利检测技术在保证检测灵敏度的前提下,可提高HBV检测的效率,降低检测成本,并且不依赖专业设备和技术人员,具有易推广普及等优势。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN113667668A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN113667668A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN113667668A3</originalsourceid><addsrcrecordid>eNrjZNDwcApTSEktSU0uyczPU0hKLE5NUQAynIM8gwOC9J0TixWKK4tLUnN5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8s5-hobGZmbmZmYWjMTFqADjlJwA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HBV detection based on CRISPR/Cas system</title><source>esp@cenet</source><creator>YUAN MINGZHU ; DUAN GUANGCAI ; YANG HAIYAN ; XI YUANLIN ; DING RONGHUA ; JIN LEFEI ; CHEN SHUAIYIN</creator><creatorcontrib>YUAN MINGZHU ; DUAN GUANGCAI ; YANG HAIYAN ; XI YUANLIN ; DING RONGHUA ; JIN LEFEI ; CHEN SHUAIYIN</creatorcontrib><description>The invention provides brand-new HBV recognition targets (region 1 and region 2), and further provides brand-new crRNA. The sequence of the crRNA disclosed by the invention can be as shown in SEQ ID NO. 3 or SEQ ID NO. 4. The invention also provides a kit based on CRISPR, and the kit comprises any one of the crRNA. On the premise of ensuring the detection sensitivity, the detection technology can improve the HBV detection efficiency and reduce the detection cost, does not depend on professional equipment and technicians, and has the advantages of being easy to popularize and the like. 本发明提供了全新的HBV识别靶点region1、region2,还提供了全新的crRNA。本发明的crRNA,其序列可如SEQ ID NO.3或SEQ ID NO.4所示。本发明还提供了基于CRISPR的试剂盒,其包含任一所述crRNA。本专利检测技术在保证检测灵敏度的前提下,可提高HBV检测的效率,降低检测成本,并且不依赖专业设备和技术人员,具有易推广普及等优势。</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; COMPOSITIONS THEREOF ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; CULTURE MEDIA ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211119&amp;DB=EPODOC&amp;CC=CN&amp;NR=113667668A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211119&amp;DB=EPODOC&amp;CC=CN&amp;NR=113667668A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YUAN MINGZHU</creatorcontrib><creatorcontrib>DUAN GUANGCAI</creatorcontrib><creatorcontrib>YANG HAIYAN</creatorcontrib><creatorcontrib>XI YUANLIN</creatorcontrib><creatorcontrib>DING RONGHUA</creatorcontrib><creatorcontrib>JIN LEFEI</creatorcontrib><creatorcontrib>CHEN SHUAIYIN</creatorcontrib><title>HBV detection based on CRISPR/Cas system</title><description>The invention provides brand-new HBV recognition targets (region 1 and region 2), and further provides brand-new crRNA. The sequence of the crRNA disclosed by the invention can be as shown in SEQ ID NO. 3 or SEQ ID NO. 4. The invention also provides a kit based on CRISPR, and the kit comprises any one of the crRNA. On the premise of ensuring the detection sensitivity, the detection technology can improve the HBV detection efficiency and reduce the detection cost, does not depend on professional equipment and technicians, and has the advantages of being easy to popularize and the like. 本发明提供了全新的HBV识别靶点region1、region2,还提供了全新的crRNA。本发明的crRNA,其序列可如SEQ ID NO.3或SEQ ID NO.4所示。本发明还提供了基于CRISPR的试剂盒,其包含任一所述crRNA。本专利检测技术在保证检测灵敏度的前提下,可提高HBV检测的效率,降低检测成本,并且不依赖专业设备和技术人员,具有易推广普及等优势。</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>COMPOSITIONS THEREOF</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDwcApTSEktSU0uyczPU0hKLE5NUQAynIM8gwOC9J0TixWKK4tLUnN5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8s5-hobGZmbmZmYWjMTFqADjlJwA</recordid><startdate>20211119</startdate><enddate>20211119</enddate><creator>YUAN MINGZHU</creator><creator>DUAN GUANGCAI</creator><creator>YANG HAIYAN</creator><creator>XI YUANLIN</creator><creator>DING RONGHUA</creator><creator>JIN LEFEI</creator><creator>CHEN SHUAIYIN</creator><scope>EVB</scope></search><sort><creationdate>20211119</creationdate><title>HBV detection based on CRISPR/Cas system</title><author>YUAN MINGZHU ; DUAN GUANGCAI ; YANG HAIYAN ; XI YUANLIN ; DING RONGHUA ; JIN LEFEI ; CHEN SHUAIYIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN113667668A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2021</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>COMPOSITIONS THEREOF</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>YUAN MINGZHU</creatorcontrib><creatorcontrib>DUAN GUANGCAI</creatorcontrib><creatorcontrib>YANG HAIYAN</creatorcontrib><creatorcontrib>XI YUANLIN</creatorcontrib><creatorcontrib>DING RONGHUA</creatorcontrib><creatorcontrib>JIN LEFEI</creatorcontrib><creatorcontrib>CHEN SHUAIYIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YUAN MINGZHU</au><au>DUAN GUANGCAI</au><au>YANG HAIYAN</au><au>XI YUANLIN</au><au>DING RONGHUA</au><au>JIN LEFEI</au><au>CHEN SHUAIYIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HBV detection based on CRISPR/Cas system</title><date>2021-11-19</date><risdate>2021</risdate><abstract>The invention provides brand-new HBV recognition targets (region 1 and region 2), and further provides brand-new crRNA. The sequence of the crRNA disclosed by the invention can be as shown in SEQ ID NO. 3 or SEQ ID NO. 4. The invention also provides a kit based on CRISPR, and the kit comprises any one of the crRNA. On the premise of ensuring the detection sensitivity, the detection technology can improve the HBV detection efficiency and reduce the detection cost, does not depend on professional equipment and technicians, and has the advantages of being easy to popularize and the like. 本发明提供了全新的HBV识别靶点region1、region2,还提供了全新的crRNA。本发明的crRNA,其序列可如SEQ ID NO.3或SEQ ID NO.4所示。本发明还提供了基于CRISPR的试剂盒,其包含任一所述crRNA。本专利检测技术在保证检测灵敏度的前提下,可提高HBV检测的效率,降低检测成本,并且不依赖专业设备和技术人员,具有易推广普及等优势。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN113667668A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title HBV detection based on CRISPR/Cas system
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T18%3A11%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YUAN%20MINGZHU&rft.date=2021-11-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN113667668A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true